Abiopharma

🔍 Smith Chad M. (Executive)

Company: Better Home & Finance Holding Co (BETR)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 11,243 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,243.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 10,000 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,936.00 | transaction_form_type: 4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 25,209.00 | Footnotes: F2
• Sold 10,000 shares of Restricted Stock Units (Class A) (Derivative)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 25,000.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: Represents grant of restricted stock units ("RSUs") that vested immediately and were granted pursuant to a compensatory arrangement approved by the Issuer's board of directors.
• F2: The shares of Class A Common Stock held by the reporting person prior to the transaction reported herein reflect a transfer of 1,693 shares previously reported as directly held by the reporting person to the reporting person's Trust, which transfer of shares to the Trust was a change in form of ownership in accordance Rule 16a-13.
• F3: Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• F4: The RSUs reported herein vested on an accelerated basis pursuant to acceleration approved by the Issuer's board of directors.